Overview

Early Use of Ivabradine in Heart Failure

Status:
Unknown status

Trial end date:
2019-12-23

Target enrollment:

Participant gender:

Summary

The aim of the work is to Evaluate the efficacy, quality of life and safety of early addition of ivabradine to B-blocker in reduced EF heart failure patients after acute decompensation compared to the standard treatment.

Phase:

N/A

Details

Lead Sponsor:

Ain Shams University

Collaborator:

Sadat City University

Treatments:

Bisoprolol